本页面由Tiger Trade Technology Pte. Ltd.提供服务

NovoCure Limited

13.92
+0.17001.24%
成交量:56.06万
成交额:786.63万
市值:15.87亿
市盈率:-8.66
高:14.38
开:13.49
低:13.26
收:13.75
52周最高:21.55
52周最低:9.82
股本:1.14亿
流通股本:9,414.79万
量比:0.59
换手率:0.60%
股息:- -
股息率:- -
每股收益(TTM):-1.6074
每股收益(LYR):-1.5638
净资产收益率:-50.60%
总资产收益率:-8.30%
市净率:4.65
市盈率(LYR):-8.90

数据加载中...

2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/11

重要事件披露

Form 8-K - Current report
2026/02/05

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/01

重要事件披露

Form 8-K - Current report
2025/10/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/09/15

重要事件披露

Form 8-K - Current report
2025/08/28

重要事件披露

Form 8-K - Current report
2025/07/24

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/24

重要事件披露

Form 8-K - Current report
2025/07/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments